View
Page
Zeus Capital's note out this morning on Research Tree: "Deltex Medical Group plc (DEMG), the global leader in the field of Oesophageal Doppler Monitoring (ODM), today announced excellent initial results from the largest ever randomised clinical trial (conducted in 450 patients undergoing major surgery in 5 hospitals in Spain) assessing the impact of oesophageal Doppler monitoring (ODM) on post-operative complications. As a result of these findings, presented at the Euroanaesthesia 2016 conference in London, ODM is indicated as the preferred method for intra-operative fluid manage..."
Latest from the Community...
Latest from the Community...
Latest from the Community...